1-5 of 5
Christine P. Hans
Close
Sort by
Journal Articles

LMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma in the Pre- and Post-Rituximab Treatment Eras.

Yasodha Natkunam, MD, PhD, Pedro Farinha, Eric D. Hsi, Christine P. Hans, Robert Tibshirani, Laurie H. Sehn, Joseph M. Connors, Shuchun Zhao, Brad Pohlman, John Spinelli, Martin Bast, Arnon Nagler, Ronald Levy, Randy D. Gascoyne, Izidore S. Lossos
Journal: Blood
Blood (2007) 110 (11): 52.
https://doi.org/10.1182/blood.V110.11.52.52
Published: 2007
Journal Articles

Prognostic Significance of VEGF, VEGF Receptors, and Microvessel Density in Diffuse Large B Cell Lymphoma Treated with Anthracycline-Based Chemotherapy.

Dita Gratzinger, MD, PhD, Shuchun Zhao, MS, Robert J. Tibshirani, PhD, Eric D. Hsi, MD, Christine P. Hans, MD, Brad Pohlman, MD, Martin Bast, Abraham Avigdor, MD, Ginette Schiby, MD, Arnon Nagler, Gerald E. Byrne, MD, Izidore S. Lossos, MD, Yasodha Natkunam, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 53.
https://doi.org/10.1182/blood.V110.11.53.53
Published: 2007
Journal Articles

Patients with Follicular Lymphoma, Grade 3, Have a Prolonged Relapse-Free Survival Following Aggressive Combination Chemotherapy.

Apar Kishor Ganti, MD, Dennis D. Weisenburger, MD, Lynette M. Smith, MS, Christine P. Hans, MD, R. Gregory Bociek, MD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, The Nebraska Lymphoma Study Group
Journal: Blood
Blood (2004) 104 (11): 613.
https://doi.org/10.1182/blood.V104.11.613.613
Published: 2004
Journal Articles

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Christine P. Hans, Dennis D. Weisenburger, Timothy C. Greiner, Randy D. Gascoyne, Jan Delabie, German Ott, H. Konrad Müller-Hermelink, Elias Campo, Rita M. Braziel, Elaine S. Jaffe, Zenggang Pan, Pedro Farinha, Lynette M. Smith, Brunangelo Falini, Alison H. Banham, Andreas Rosenwald, Louis M. Staudt, Joseph M. Connors, James O. Armitage, Wing C. Chan
Journal: Blood
Blood (2004) 103 (1): 275–282.
https://doi.org/10.1182/blood-2003-05-1545
Published: 2004
Journal Articles

A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival

Clinical Trials & Observations
Christine P. Hans, Dennis D. Weisenburger, Julie M. Vose, Lynette M. Hock, James C. Lynch, Patricia Aoun, Timothy C. Greiner, Wing C. Chan, Robert G. Bociek, Philip J. Bierman, James O. Armitage
Journal: Blood
Blood (2003) 101 (6): 2363–2367.
https://doi.org/10.1182/blood-2002-07-2298
Published: 2003